Delivery Order SPE2DB22D1106-SPE2DB25FDJR2
Award Date
10/31/24
Potential Completion Date
11/1/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,150.03, is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of April 4, 2025 and is a firm fixed-price delivery order. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is for the delivery of a specific pharmaceutical product, ADBRY 300 MG/2 ML AUTOINJECTOR 2ML. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,980.96 firm fixed price delivery order covers the supply of ADBRY 150 MG/ML SYRINGEML, a medical product, with an ultimate completion date of December 3, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a ceiling value of $1,020.88. The contract has an ultimate completion date of June 10, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,120.24, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth up to $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award, valued at $16,464.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that runs through December 24, 2024 and is priced on a firm fixed-price basis. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,364.74 firm-fixed-price delivery order contract is for the provision of ADBRY 150 MG/ML SYRINGEML, a pharmaceutical product. This award is under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML. The contract has a firm fixed price of $5,854.76 and a performance period ending on June 5, 2025. The contract is not set aside and was awarded on June 4, 2025. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a $4,695.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a period of performance through March 3, 2025. The contract is a firm fixed price, Indefinite Delivery Contract (IDC) without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,415.48, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, worth $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...